Long-term treatment effects of vitamin E for tardive dyskinesia

Biological Psychiatry

Volumn 43, Issue 12, 1998, Pages 868-872

  Adler, Lenard A ^a   Edson, Robert ^b   Lavori, Philip ^b   Peselow, Eric ^a   Duncan, Erica ^a   Rosenthal, Michel ^a   Rotrosen, John ^a  

^a Psychiatry Service   (United States)

^b VA Coop Studs Prog Coord Center   (United States)

Author keywords

Abnormal Involuntary Movements Scale; Antioxidant; Free radicals; Linear mixed effects regression; Tardive dyskinesia; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; TIME FACTORS; VITAMIN E;

EID: 0032526659     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00027-9     Document Type: Article

References (19)

1. Adler L.A., Peselow E., Rotrosen J., Duncan E., Lee M., Rosenthal M., et al. Vitamin E treatment of tardive dyskinesia. Am J Psychiatry. 150:1993;1405-1407.
2. Adler L.A., Peselow E., Duncan E., Rosenthal M., Angrist B. Vitamin E in tardive dyskinesia Time course of effect after placebo substitution . Psychopharmacol Bull. 29:1993;371-374.
3. Dabiri L.M., Pasta D., Darby J.K., Mosbacher D. Effectiveness of Vitamin E for treatment of long-term tardive dyskinesia. Am J Psychiatry. 151:1994;925-926.
4. Egan M.T., Hyde T., Albers G., Elkashef A., Alexander R.C., Reeve A., et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry. 149:1992;773-777.
5. Elkashef A.M., Ruskin P.E., Bacher N., Barrett D. Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry. 147:1990;505-506.
6. Gelenberg A.J. Antipsychotic drugs. Bassuk E.L., Schooner S.C., Gelenberg A.J. The Practitioner's Guide to Psychoactive Drugs. 2nd ed. 1983;124 Plenum Medical Book Company, New York.
7. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics. 38:1982;963-974.
8. Lam L.C.W., Chin H.F.K., Hung S.F. Vitamin E in the treatment of tardive dyskinesia A replication study . J Nerv Ment Dis. 182:1994;113-114.
9. Lindstrom M.J., Bates D.M. Newton-Raphson and EM algorithms for linear mixed-effects models for repeated-measures data. J Am Stat Assoc. 83:1988;1014-1022.
10. Little R.J.A., Rubin D.B. Statistical Analysis with Missing Data. 1987;Wiley, New York.
11. Lohr J.B. Oxygen radicals and neuropsychiatric illness. Arch Gen Psychiatry. 48:1992;1097-1106.
12. Lohr JB (1993): Vitamin E treatment of tardive dyskinesia. Presented at the 1993 Annual Meeting of the American Psychiatric Association, San Francisco, California, May.
13. Lohr J.B., Cadet J.L., Lohr M.A., Jeste D.V., Wyatt R.J. Alpha-tocopherol in tardive dyskinesia. Lancet. i:1987;913-914.
14. Development of a dyskinetic movement scale. ECDEU Intercom. 4:1975;3-6.
15. Peet M., Laugharne J., Rangarajan N., Reynolds G.P. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int Clin Psychopharmacol. 8:1993;151-153.
16. Schooler N., Kane J.M. Research diagnoses for tardive dyskinesia (RD-TD). Arch Gen Psychiatry. 39:1992;486-487.
17. Senn S.J., AuClair P. The graphical representation of clinical trials with particular reference to measurements over time. Stat Med. 9:1990;1287-1302.
18. Shriqui C.L., Bradwejn J., Annable L., Jones B.D. Vitamin E in the treatment of tardive dyskinesia A double-blind placebo controlled study . Am J Psychiatry. 149:1992;391-393.
19. Spivak B., Schwartz B., Radwan M., Weizman A. Alpha-tocopherol treatment for tardive dyskinesia. J Nerv Ment Dis. 180:1992;400-401.